Cinacalcet

FDA Drug Profile — Cinacalcet, CINACALCET, Cinacalcet Hydrochloride

Cinacalcet is listed in the FDA National Drug Code directory with 47 NDC codes, marketed under brand names including Cinacalcet, CINACALCET, Cinacalcet Hydrochloride. Available dosage forms: tablet, film coated, tablet.

Drug details

Generic Name
Cinacalcet
Brand Names
Cinacalcet, CINACALCET, Cinacalcet Hydrochloride
Application Number
ANDA209226
Sponsor
American Health Packaging
NDC Codes
47
Dosage Forms
TABLET, FILM COATED, TABLET
Routes
ORAL
Active Ingredients
CINACALCET HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE Cinacalcet is a positive modulator of the calcium sensing receptor indicated for: Secondary Hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on dialysis. ( 1.1 ) Limitations of Use: Cinacalcet is not indicated for use in patients with CKD who are not on dialysis Hypercalcemia in adult patients with Parathyroid Carcinoma (PC). ( 1.2 ) Severe hypercalcemia in adult patients with primary HPT who are unable to parathyroidectomy. ( 1.3 ) 1.1 Secondary Hyperparathyroidism Cinacalcet tablets are indicated for the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on dialysis [see Clinical Studies (14.1) ]. Limitations of Use: Cinacalcet tablets are not indicated for use in patients with CKD who are not on dialysis because of an increased risk of hypocalcemia [see Warnings and Precautions (5.1) ] 1.2 Parathyroid Carcinoma Cinacalcet tablets are indicated for the treatment of hypercalcemia in adult patients with Parathyroid Carcinoma [see Clinical Studies (14.2) ]. 1.3 Primary Hyperparathyroidism Cinacalcet tablets are indicated for the treatment of severe hypercalcemia in adult patients with primary HPT who are unable to undergo parathyroidectomy [see Clinical Studies (14.3) ].

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.